2021
DOI: 10.1007/s00415-021-10538-1
|View full text |Cite
|
Sign up to set email alerts
|

Management considerations for stroke-like episodes in MELAS with concurrent COVID-19 infection

Abstract: There have been considerations since the beginning of the Coronavirus pandemic that COVID-19 infection, like any other viral illness, can trigger neurological and metabolic decompensation in patients with mitochondrial diseases. At the time of writing, there were no published reports reviewing experiences and guidelines about management of COVID-19 infection in this patient population. We present a challenging case of an adult patient with a known diagnosis of Mitochondrial Encephalomyopathy, Lactic Acidosis a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 17 publications
(20 reference statements)
0
1
0
Order By: Relevance
“…Evidence that the immune system is altered by an energetic defect come from multiple reports where MD patients have similar presentations to patients with primary immunodeficiencies, including unusual infections not commonly diagnosed in immunocompetent people [48]. Leukopenia has been reported in different MDs, including Barth syndrome, Pearson syndrome, Leigh syndrome, and other nonsyndromic forms of MD [49][50][51][52][53][54][55][56]. Recurrent hypogammaglobulinemia and reductions in natural killer, total CD8 T cells, and CD8 memory T cells were also noted [57].…”
Section: Mitochondrial Diseasesmentioning
confidence: 99%
“…Evidence that the immune system is altered by an energetic defect come from multiple reports where MD patients have similar presentations to patients with primary immunodeficiencies, including unusual infections not commonly diagnosed in immunocompetent people [48]. Leukopenia has been reported in different MDs, including Barth syndrome, Pearson syndrome, Leigh syndrome, and other nonsyndromic forms of MD [49][50][51][52][53][54][55][56]. Recurrent hypogammaglobulinemia and reductions in natural killer, total CD8 T cells, and CD8 memory T cells were also noted [57].…”
Section: Mitochondrial Diseasesmentioning
confidence: 99%
“…However, by searching PubMed with the terms "mitochondrial, COVID* OR mitochondrial, coronavirus*", to date (3 November 2021), there is no empirical evidence of a heightened risk for a severe outcome of COVID-19 in these subjects, except from an isolated report of a patient with pre-existing severe MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) further complicated by COVID-19 [3].…”
mentioning
confidence: 99%